NCT05804825

Brief Summary

The investigators will recruit a national sample of parents of 7-10-year-olds to complete an argument strength ranking for either a simple forwarding message or between 3 and 6 randomly selected arguments from an overall set of 50 to 100 messages identified from various online sources. Parents will rate each message they see on measures of perceived argument strength/PME. Parents will also answer sociodemographic questions and then rank the believability of a set of anti-vaccine messages identified in a different study. Study findings will contribute valuable information to understanding the effectiveness of different inoculation messages.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
523

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

October 20, 2022

Completed
6 months until next milestone

First Posted

Study publicly available on registry

April 7, 2023

Completed
27 days until next milestone

Study Start

First participant enrolled

May 4, 2023

Completed
20 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 24, 2023

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

May 24, 2023

Completed
Last Updated

July 11, 2023

Status Verified

July 1, 2023

Enrollment Period

20 days

First QC Date

October 20, 2022

Last Update Submit

July 7, 2023

Conditions

Keywords

misinformationHPV vaccinevaccine hesitancy

Outcome Measures

Primary Outcomes (2)

  • Argument strength/PME

    Arguments will be rated for their argument strength/message effectiveness

    The outcome measure will be assessed immediately after the participant has viewed each pro-HPV vaccine message if they are in the multiple message condition, or the simple message if they are in the simple message condition stimuli during the survey.

  • Misinformation believability

    A rating of the believability/ credibility of vaccine misinformation

    The outcome measure will be assessed immediately after the participant has viewed each misinformation message during the survey.

Study Arms (2)

Simple forewarning message

ACTIVE COMPARATOR

Participants will receive a simple short forewarning message to read and rate.

Behavioral: Simple forewarning message

Argument inoculation messages

EXPERIMENTAL

Participants will view a random sample of 3 text-only short messages (from a corpus of 100 arguments) to read and rate.

Behavioral: Argument inoculation messages

Interventions

Participants will then be presented with arguments randomly selected by the Qualtrics software algorithm from the full set of messages.

Argument inoculation messages

Participants will be presented with a simple forewarning message.

Simple forewarning message

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female parent or legal guardian of an adolescent ages 7-10
  • Age eligible child has not yet received any doses of the HPV vaccine
  • Resides in the United States
  • English speaking
  • Completed informed consent

You may not qualify if:

  • Unable to read English at a 6th grade literacy level
  • Age \< 18
  • Does not have a child within the age range of 7-10
  • Age-eligible child has received 1 or more doses of the HPV vaccine
  • Unwilling or unable to provide informed consent to study participation

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

UPenn

Philadelphia, Pennsylvania, 19104, United States

Location

MeSH Terms

Conditions

Vaccination HesitancyVaccination RefusalCommunication

Condition Hierarchy (Ancestors)

Treatment RefusalTreatment Adherence and ComplianceHealth BehaviorBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Model Details: randomized discrete choice modeling experiment design
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

October 20, 2022

First Posted

April 7, 2023

Study Start

May 4, 2023

Primary Completion

May 24, 2023

Study Completion

May 24, 2023

Last Updated

July 11, 2023

Record last verified: 2023-07

Locations